LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration

Journal of Experimental Medicine

Volumn 201, Issue 3, 2005, Pages 409-418

  Liu, Lixin ^a   Cara, Denise C ^a   Kaur, Jaswinder ^a   Raharjo, Eko ^a   Mullaly, Sarah C ^a   Jongstra Bilen, Jenny ^b,c   Jongstra, Jan ^b,c   Kubes, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN LSP1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CAPILLARY; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CHIMERA; ENDOTHELIUM CELL; EXTRAVASATION; IMMUNOFLUORESCENCE MICROSCOPY; KERATINOCYTE; LEUKOCYTE; MICROVASCULATURE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VENULE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BONE MARROW TRANSPLANTATION; CALCIUM-BINDING PROTEINS; CAPILLARY PERMEABILITY; CELL ADHESION; CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; ENDOTHELIUM; HEMODYNAMIC PROCESSES; HISTAMINE; HUMANS; INTERLEUKIN-1; LEUKOCYTES; MALE; MICE; MICE, KNOCKOUT; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; TRANSPLANTATION CHIMERA; TUMOR NECROSIS FACTOR-ALPHA; VENULES;

EID: 13644270346     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20040830     Document Type: Article

References (54)

1. 2+-binding protein is not expressed in transformed T lymphocyte lines. J. Immunol. 141:3999-4004.
2. Jongstra-Bilen, J., A.J. Young, R. Chong, and J. Jongstra. 1990. Human and mouse LSP1 genes code for highly conserved phosphoproteins. J. Immunol. 144:1104-1110.
3. Pulford, K., M. Jones, A.H. Banham, E. Haralambieva, and D.Y. Mason. 1999. Lymphocyte-specific protein 1: a specific marker of human leucocytes. Immunology. 96:262-271.
4. Jongstra, J., M.E. Ittel, N.N. Iscove, and G. Brady. 1994. The LSP1 gene is expressed in cultured normal and transformed mouse macrophages. Mol. Immunol. 31:1125-1131.
5. Li, Y., A. Guerrero, and T.H. Howard. 1995. The actin-binding protein, lymphocyte-specific protein 1, is expressed in human leukocytes and human myeloid and lymphoid cell lines. J. Immunol. 155:3563-3569.
6. 2+-binding protein LSP1 is associated with the cytoplasmic face of the plasma membrane. Mol. Cell. Biol. 9:3043-3048.
7. Klein, D.P., S. Galea, and J. Jongstra. 1990. The lymphocyte-specific protein LSP1 is associated with the cytoskeleton and co-caps with membrane IgM. J. Immunol. 145:2967-2973.
8. Jongstra-Bilen, J., P.A. Janmey, J.H. Hartwig, S. Galea, and J. Jongstra. 1992. The lymphocyte-specific protein LSP1 binds to F-actin and to the cytoskeleton through its COOH-terminal basic domain. J. Cell Biol. 118:1443-1453.
9. Zhang, Q., Y. Li, and T.H. Howard. 2000. Human lymphocyte-specific protein 1, the protein overexpressed in neutrophil actin dysfunction with 47-kDa and 89-kDa protein abnormalities (NAD 47/89), has multiple F-actin binding domains. J. Immunol. 165:2052-2058.
10. Huang, C.K., L. Zhan, Y. Ai, and J. Jongstra. 1997. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272:17-19.
11. -/- neutrophils in Zigmond chambers containing formyl-methionyl-leucyl-phenylalanine gradients. J. Immunol. 167:3953-3961.
12. Zu, Y.L., J. Qi, A. Gilchrist, G.A. Fernandez, D. Vazquez-Abad, D.L. Kreutzer, C.K. Huang, and R.I. Sha'afi. 1998. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation. J. Immunol. 160:1982-1989.
13. Cara, D.C., J. Kaur, M. Forster, D.M. McCafferty, and P. Kubes. 2001. Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J. Immunol. 167:6552-6558.
14. Stokoe, D., K. Engel, D.G. Campbell, P. Cohen, and M. Gaestel. 1992. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett. 313:307-313.
15. Carballo, E., D. Colomer, J.L. Vives-Corrons, P.J. Blackshear, and J. Gil. 1996. Characterization and purification of a protein kinase C substrate in human B cells. Identification as lymphocyte-specific protein 1 (LSP1). J. Immunol. 156:1709-1713.
16. Matsumoto, N., S. Kojima, T. Osawa, and S. Toyoshima. 1995. Protein kinase C phosphorylates p50 LSP1 and induces translocation of p50 LSP1 in T lymphocytes. J. Biochem. (Tokyo). 117:222-229.
17. Laudanna, C., D. Mochly-Rosen, T. Liron, G. Constantin, and E.C. Butcher. 1998. Evidence of ζ protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J. Biol. Chem. 273:30306-30315.
18. Jongstra-Bilen, J., V.L. Misener, C. Wang, H. Ginzberg, A. Auerbach, A.L. Joyner, G.P. Downey, and J. Jongstra. 2000. LSP1 modulates leukocyte populations in resting and inflamed peritoneum. Blood. 96:1827-1835.
19. Wang, C., H. Hayashi, R. Harrison, B. Chiu, J.R. Chan, H.L. Ostergaard, R.D. Inman, J. Jongstra, M.I. Cybulsky, and J. Jongstra-Bilen. 2002. Modulation of Mac-1 (CD11b/CD18)-mediated adhesion by the leukocyte-specific protein 1 is key to its role in neutrophil polarization and chemotaxis. J. Immunol. 169:415-423.
20. Hannigan, M., L. Zhan, Y. Ai, and C.K. Huang. 2001. Leukocyte-specific gene 1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganization in murine neutrophils in vitro. J. Leukoc. Biol. 69:497-504.
21. Luscinskas, F.W., S. Ma, A. Nusrat, C.A. Parkos, and S.K. Shaw. 2002. Leukocyte transendothelial migration: a junctional affair. Semin. Immunol. 14:105-113.
22. Vestweber, D. 2002. Regulation of endothelial cell contacts during leukocyte extravasation. Curr. Opin. Cell Biol. 14:587-593.
23. Kayyali, U.S., C.M. Pennella, C. Trujillo, O. Villa, M. Gaestel, and P.M. Hassoun. 2002. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J. Biol. Chem. 277:42596-42602.
24. Park, J.H., N. Okayama, D. Gute, A. Krsmanovic, H. Battarbee, and J.S. Alexander. 1999. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am. J. Physiol. 277:C1066-C1074.
25. Huot, J., F. Houle, F. Marceau, and J. Landry. 1997. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 80:383-392.
26. Nwariaku, F.E., J. Chang, X. Zhu, Z. Liu, S.L. Duffy, N.H. Halaihel, L. Terada, and R.H. Turnage. 2002. The role of p38 MAP kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock. 18:82-85.
27. Laird, S.M., A. Graham, A. Paul, G.W. Gould, C. Kennedy, and R. Plevin. 1998. Tumour necrosis factor stimulates stress-activated protein kinases and the inhibition of DNA synthesis in cultures of bovine aortic endothelial cells. Cell. Signal. 10:473-480.
28. Rousseau, S., F. Houle, J. Landry, and J. Huot. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:2169-2177.
29. Huang, A.J., J.E. Manning, T.M. Bandak, M.C. Ratau, K.R. Hanser, and S.C. Silverstein. 1993. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J. Cell Biol. 120:1371-1380.
30. Garcia, J.G., A.D. Verin, M. Herenyiova, and D. English. 1998. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. J. Appl. Physiol. 84:1817-1821.
31. Thompson, R.D., K.E. Noble, K.Y. Larbi, A. Dewar, G.S. Duncan, T.W. Mak, and S. Nourshargh. 2001. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood. 97:1854-1860.
32. Young, R.E., R.D. Thompson, and S. Nourshargh. 2002. Divergent mechanisms of action of the inflammatory cytokines interleukin 1-β and tumour necrosis factor-α in mouse cremasteric venules. Br. J. Pharmacol. 137:1237-1246.
33. Carvalho-Tavares, J., M.J. Hickey, J. Hutchison, J. Michaud, I.T. Sutcliffe, and P. Kubes. 2000. A role for platelets and endothelial selectins in tumor necrosis factor-α-induced leukocyte recruitment in the brain microvasculature. Circ. Res. 87:1141-1148.
34. Del Maschio, A., A. Zanetti, M. Corada, Y. Rival, L. Ruco, M.G. Lampugnani, and E. Dejana. 1996. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J. Cell Biol. 135:497-510.
35. Johnson-Leger, C., M. Aurrand-Lions, and B.A. Imhof. 2000. The parting of the endothelium: miracle, or simply a junctional affair? J. Cell Sci. 113:921-933.
36. Dejana. E. 1996. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J. Clin. Invest. 98:1949-1953.
37. Dejana, E., R. Spagnuolo, and G. Bazzoni. 2001. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb. Haemost. 86:308-315.
38. Waschke, J., W. Baumgartner, R.H. Adamson, M. Zeng, K. Aktories, H. Barth, C. Wilde, F.E. Curry, and D. Drenckhahn. 2004. Requirement of Rac activity for maintenance of capillary endothelial barrier properties. Am. J. Physiol. Heart Circ. Physiol. 286:H394-H401.
39. Adamson, R.H., F.E. Curry, G. Adamson, B. Liu, Y. Jiang, K. Aktories, H. Barth, A. Daigeler, N. Golenhofen, W. Ness, and D. Drenckhahn. 2002. Rho and rho kinase modulation of barrier properties: cultured endothelial cells and intact microvessels of rats and mice. J. Physiol. 539:295-308.
40. Shaw, S.K., P.S. Bamba, B.N. Perkins, and F.W. Luscinskas. 2001. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J. Immunol. 167:2323-2330.
41. Kielbassa, K., C. Schmitz, and V. Gerke. 1998. Disruption of endothelial microfilaments selectively reduces the transendothelial migration of monocytes. Exp. Cell Res. 243:129-141.
42. Hordijk, P.L., E. Anthony, F.P. Mul, R. Rientsma, L.C. Oomen, and D. Roos. 1999. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J. Cell Sci. 112:1915-1923.
43. i signaling during transmigration of polymorphonuclear leukocytes. Blood. 96:3816-3822.
44. Lum, H., and A.B. Malik. 1994. Regulation of vascular endothelial barrier function. Am. J. Physiol. 267:L223-L241.
45. Herlaar, E., and Z. Brown. 1999. p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today. 5:439-447.
46. Kaur, J., R.C. Woodman, and P. Kubes. 2003. P38 MAPK: critical molecule in thrombin-induced NF-κB-dependent leukocyte recruitment. Am. J. Physiol. Heart Circ. Physiol. 284:H1095-H1103.
47. Liu, L., and P. Kubes. 2003. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb. Haemost. 89:213-220.
48. Harrison, R.E., B.A. Sikorski, and J. Jongstra. 2004. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. J. Cell Sci. 117:2151-2157.
49. 4- integrin, P-selectin, and E-selectin in an allergic model of inflammation. J. Exp. Med. 185:1077-1087.
50. Hickey, M.J., M. Forster, D. Mitchell, J. Kaur, C. De Caigny, and P. Kubes. 2000. L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. J. Immunol. 165:7164-7170.
51. Kurose, I., P. Kubes, R. Wolf, D.C. Anderson, J. Paulson, M. Miyasaka, and D.N. Granger. 1993. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ. Res. 73:164-171.
52. 4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ. Res. 90:562-569.
53. Motoike, T., S. Loughna, E. Perens, B.L. Roman, W. Liao, T.C. Chau, C.D. Richardson, T. Kawate, J. Kuno, B.M. Weinstein, et al. 2000. Universal GFP reporter for the study of vascular development. Genesis. 28:75-81.
54. Wong, M.J., I.A. Malapitan, B.A. Sikorski, and J. Jongstra. 2003. A cell-free binding assay maps the LSP1 cytoskeletal binding site to the COOH-terminal 30 amino acids. Biochim. Biophys. Acta. 1642:17-24.